SARS-CoV-2,

Marta Iglis de Oliveira1,2, Melayne Rocha Aciole1, Patrícia Areias Feitosa Neves1

  • 1Department of Tropical Medicine, Medical Sciences Center, Federal University of Pernambuco, Recife, Pernambuco, Brazil.

BMC infectious diseases
|January 3, 2024
PubMed
概括

严重的COVID-19病例在感染后至少12个月内显示出更高和更持久的抗尖端蛋白IgG-S1抗体水平. 这一发现对于了解再感染风险和指导康复个体的疫苗接种策略至关重要.